Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New vasopressin V1A and V2 receptor antagonists described by Bayer

May 15, 2019

"Love hormone" causes heartbreak -- literally

May 15, 2019

Too much of a good thing foils heart repair

May 14, 2019

Food dye is secret ingredient for tissue-feeding vasculature

May 8, 2019

FDA approves Vyndaqel and Vyndamax for the treatment of cardiomyopathy caused by ATTR-CM

May 7, 2019

Shanxi Medical University patents EMSCs for cardiovascular diseases

May 6, 2019

Cialis returns to Viagra's roots

May 6, 2019

First patient enrolled in proof-of-concept study of ATH-3G10 in heart failure

May 2, 2019

Omeicos doses first patient in phase II study of OMT-28 for atrial fibrillation

April 29, 2019

FDA approves Praluent to reduce risk of heart attack, stroke and unstable angina

April 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...